drugset / Trial / NCT07047651

Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.

NCT07047651 ↗

Phase 4 Active not recruiting 84 enrolled Dr. Stavroula Rakitzi
RandomizedParallel-groupSingle-blindTreatment

Summary

The effectiveness and efficacy of the combination of pharmacotherapy with the two new recovery-oriented programs, RECOVERYTRSGR for patients with treatment- resistant schizophrenia and RECOVERYTRSBDGR for patients with treatment- resistant bipolar disorder.

Timeline

Start
2025-06-04
Primary completion
2027-12-20
Completion
2027-12-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Aripiprazole Other / unclassified — —
Background Asenapine Other / unclassified — —
Background Clonazepam Small molecule — —
Background Clozapine Other / unclassified — —
Background Lithium Unknown — —
Background Olanzapine Small molecule — —
Background Paliperidone Unknown — —
Background Risperidone Other / unclassified — —
Background Tavor Unknown — —
Background Zuclopenthixol Unknown — —
Background depakine Unknown — —
Background quietiapine Unknown — —
Background seropram Unknown — —
Background stedon Unknown — —
Background zyprasidone Unknown — —